首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell-depleted allogeneic hematopoietic cell transplantation.
【24h】

Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell-depleted allogeneic hematopoietic cell transplantation.

机译:T细胞贫化的异基因造血细胞移植后,打破对循环自身表达抑制性KIR的非自然HLA的自我循环耐受性,将发挥效应子功能。

获取原文
获取原文并翻译 | 示例
       

摘要

Alloreactive natural killer (NK) cells are an important influence on hematopoietic stem cell transplantation (HSCT) outcome. In HLA-mismatched HSCT, alloreactivity occurs when licensed donor NK cells expressing inhibitory killer Ig-like receptors (KIR) for donor MHC class I ligands recognize the lack of the class I ligands in the mismatched recipient ("missing self"). Studies in HLA-matched HSCT, however, have also demonstrated improved outcome in patients lacking class I ligands for donor inhibitory KIR ("missing ligand"), indicating that classically nonlicensed donor NK cells expressing KIR for non-self MHC class I ligands may exhibit functional competence in HSCT. We examined NK function in 16 recipients of T cell-depleted allografts from HLA-identical or KIR-ligand matched donors after myeloablative therapy. After HSCT, nonlicensed NK cells expressing inhibitory KIR for non-self class I exhibit robust intracellular IFN-gamma and cytotoxic response to target cells lacking cognate ligand, gradually becoming tolerized to self by day 100. These findings could not be correlated with cytokine environment or phenotypic markers of NK development, nor could they be attributed to non-KIR receptors such as CD94/NKG2A. These findings confirm that NK alloreactivity can occur in HLA-matched HSCT, where tolerance to self is either acquired by the stem cell-derived NK cell after exiting the bone marrow or where tolerance to self can be temporarily overcome.
机译:同种反应性自然杀伤(NK)细胞对造血干细胞移植(HSCT)结局具有重要影响。在HLA不匹配的HSCT中,当表达供体MHC I类配体的抑制性杀伤性Ig样受体(KIR)的许可供体NK细胞识别出错配受体中缺少I类配体时,就会发生同种反应。然而,在HLA匹配的HSCT中的研究也表明,缺乏缺乏供体抑制性KIR的I类配体(“缺失配体”)的患者的转归有所改善,表明经典的非许可供体NK细胞表达了针对非自身MHC I类配体的KIR HSCT的功能能力。我们在清髓治疗后,检查了来自HLA相同或KIR配体匹配的供体的16个T细胞缺失同种异体移植受体的NK功能。 HSCT后,表达非自身I类抑制性KIR的非许可NK细胞表现出强大的细胞内IFN-γ和对缺乏同源配体的靶细胞的细胞毒性反应,到第100天逐渐对自身具有耐受性。这些发现与细胞因子环境或NK发育的表型标记,也不能归因于非KIR受体,例如CD94 / NKG2A。这些发现证实了NK同种异体反应可以发生在HLA匹配的HSCT中,其中对自身的耐受性要么是从骨髓中分离出来的干细胞衍生的NK细胞获得的,要么是可以暂时克服对自身的耐受性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号